Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

WILMINGTON, Massachusetts, September 22 /PRNewswire/ --

Xenon Corp., a company internationally recognized as a leader and pioneer in the field of Pulsed Light systems, might have found the silver bullet that researchers have been seeking to increase vitamin D in their fight against disease.

It's called Pulsed light. It's brighter than the sun and in short pulses -- flashed on mushrooms -- increases the vitamin D content in mushrooms substantially.

LONDON, September 22 /PRNewswire/ --

- Distribution of Eurex(R) Derivatives, Deutsche Borse Indices and Stoxx(R) Indices Data to Asian Retail Investors Via Blue Mobile(TM)

GLOUCESTER, England, September 22 /PRNewswire/ --

- More Evidence of the Unique Joint-Protection Properties of GOPO(R)

The latest evidence for the unique joint-protection properties of a patented rose-hip powder - which is proving increasingly popular with sufferers of joint conditions such as osteoarthritis (OA) - was announced this weekend (18-21 September 2008) at the OARSI (Osteoarthritis Research Society International) World Congress of Osteoarthritis in Rome. Scientists and doctors from around the world heard the latest results from two major studies exploring the mechanism of action of GOPO(R) - the active ingredient found in only one proprietary brand of rose-hip powder (LitoZin(R)) available in the UK.

VENLO, Netherlands, September 21 /PRNewswire/ --

- QIAGEN's careHPV test provides 'substantially more accurate' front-line screening

A new HPV test developed by QIAGEN specifically for use in regions of the world with scarce resources is "substantially" more accurate in identifying women with cervical disease than the current methods (Pap testing and visual inspection) in these countries. The first published study of patient outcomes with QIAGEN's careHPV test -- developed with support from PATH, a non-profit global health organization -- appears in the October issue of Lancet Oncology.

LONDON, September 19 /PRNewswire/ -- Data Explorers are announcing today a new monitoring service (http://www.dataexplorers.com/rsm) covering all stocks with short selling restrictions recently applied by the SEC and FSA. These stocks now require specific regulatory filings and Data Explorers will combine these with their extensive global short side intelligence database.

Data Explorers has been providing transparency to the Securities Lending industry for the past 6 years. The company delivers unique data provided directly by the Securities Lending market participants. As short selling information becomes increasingly public, Data Explorers will integrate it with their proprietary data to provide increasing transparency in this large and important market.

LONDON, September 19 /PRNewswire/ -- Cambian Healthcare and re:source won the 2008 Independent Healthcare Award for their ground-breaking partnership to improve the lives of patients with mental illness. The award was judged by the Healthcare Commission.

The award recognises a new innovative programme that enables long-stay hospital patients to return to their communities.

In 2007, 47 patients from the East Midlands were transferred to Cambian's Intensive Psychiatric Rehabilitation Programme. The programme uses high staff ratios and intensive clinical inputs to work closely with these patients to rebuild their daily living skills and confidence.